Profilin 1-mediated cytoskeletal rearrangements regulate integrin function in mouse platelets by Stritt, Simon et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Profilin 1-mediated cytoskeletal rearrangements regulate integrin function in
mouse platelets
Stritt, Simon; Birkholz, Inga; Beck, Sarah; Sorrentino, Simona; Sapra, K Tanuj; Viaud, Julien; Heck,
Johannes; Gaits-Iacovoni, Frédérique; Schulze, Harald; Du, Xiaoping; Hartwig, John H; Braun, Attila;
Bender, Markus; Medalia, Ohad; Nieswandt, Bernhard
Abstract: Platelet adhesion and aggregation at sites of vascular injury is essential for hemostasis but
may also cause thrombosis.1 Firm platelet adhesion is mediated by heterodimeric receptors of the ￿1-
and ￿3-integrin families, which upon activation reversibly shift to a high-affinity state and efficiently
bind their ligands, most notably components of the extracellular matrix and other receptors.2￿-4 Bind-
ing of talin-1 (Tln1) and kindlins to the intracellular tail of the integrin ￿-subunit triggers the switch
to the high-affinity state, whereas their dissociation results in integrin closure, the switch back to the
low-affinity state.5￿￿-8 Tln1 and kindlins connect integrins to the actin cytoskeleton, thereby enabling the
sensing and exertion of mechanical forces as well as regulating adhesion formation and turnover.9￿￿-12
Consistently, defects in actin-regulating proteins result in altered platelet and megakaryocyte integrin
function.13￿￿￿￿￿-19 Furthermore, we have recently shown a critical role of twinfilin 2a (Twf2a) and the cor-
tical cytoskeleton in regulating platelet integrin turnover in a profilin 1 (Pfn1)–dependent manner.10 The
small actin-binding protein Pfn1 is central for actin dynamics by mediating the nucleotide exchange on
G-actin monomers, thereby promoting filament assembly with implications for platelet biogenesis.13,20
Megakaryocyte-specific Pfn1 deficiency resulted in microthrombocytopenia because of cytoskeletal alter-
ations and accelerated platelet clearance (supplemental Figure 1).13 However, the precise role of Pfn1
for platelet function is unknown. Here, we report that the lack of Pfn1 in platelets (Pfn1fl/fl-Pf4Cre)
perturbs the organization of the adhesion-dependent circumferential actin network and thereby results
in accelerated integrin inactivation and hence impaired platelet function in vitro and in vivo.
DOI: https://doi.org/10.1182/bloodadvances.2017014001
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-151955
Published Version
Originally published at:
Stritt, Simon; Birkholz, Inga; Beck, Sarah; Sorrentino, Simona; Sapra, K Tanuj; Viaud, Julien; Heck,
Johannes; Gaits-Iacovoni, Frédérique; Schulze, Harald; Du, Xiaoping; Hartwig, John H; Braun, Attila;
Bender, Markus; Medalia, Ohad; Nieswandt, Bernhard (2018). Profilin 1-mediated cytoskeletal rear-
rangements regulate integrin function in mouse platelets. Blood advances, 2(9):1040-1045.
DOI: https://doi.org/10.1182/bloodadvances.2017014001
STIMULUS REPORT
Proﬁlin 1–mediated cytoskeletal rearrangements regulate integrin
function in mouse platelets
Simon Stritt,1,2,* Inga Birkholz,1,2,* Sarah Beck,1,2 Simona Sorrentino,3 K. Tanuj Sapra,3 Julien Viaud,4 Johannes Heck,1 Fre´de´rique Gaits-
Iacovoni,4 Harald Schulze,1 Xiaoping Du,5 John H. Hartwig,6 Attila Braun,1,2 Markus Bender,1,2 Ohad Medalia,3,7 and Bernhard Nieswandt1,2
1Institute of Experimental Biomedicine I, University Hospital, and 2Rudolf Virchow Center, University of Wu¨rzburg, Wu¨rzburg, Germany; 3Department of Biochemistry, University
of Zurich, Zurich, Switzerland; 4INSERM, U1048 and Universite´ Toulouse 3, Toulouse, France; 5Department of Pharmacology, University of Illinois, Chicago, IL; 6Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA; and 7Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University,
Beer-Sheva, Israel
Key Points
• Profilin 1–mediated
cytoskeletal dynamics
regulate platelet b1-
and b3-integrin
function and turnover.
• Profilin 1 deficiency in
platelets impairs hemo-
stasis and results in a
marked protection from
arterial thrombosis.
Introduction
Platelet adhesion and aggregation at sites of vascular injury is essential for hemostasis but may also
cause thrombosis.1 Firm platelet adhesion is mediated by heterodimeric receptors of the b1- and b3-
integrin families, which upon activation reversibly shift to a high-affinity state and efficiently bind their
ligands, most notably components of the extracellular matrix and other receptors.2-4 Binding of talin-1
(Tln1) and kindlins to the intracellular tail of the integrin b-subunit triggers the switch to the high-affinity
state, whereas their dissociation results in integrin closure, the switch back to the low-affinity state.5-8
Tln1 and kindlins connect integrins to the actin cytoskeleton, thereby enabling the sensing and exertion
of mechanical forces as well as regulating adhesion formation and turnover.9-12 Consistently, defects in
actin-regulating proteins result in altered platelet and megakaryocyte integrin function.13-19 Furthermore,
we have recently shown a critical role of twinfilin 2a (Twf2a) and the cortical cytoskeleton in regulating
platelet integrin turnover in a profilin 1 (Pfn1)–dependent manner.10
The small actin-binding protein Pfn1 is central for actin dynamics by mediating the nucleotide exchange on
G-actin monomers, thereby promoting filament assembly with implications for platelet biogenesis.13,20
Megakaryocyte-specific Pfn1 deficiency resulted in microthrombocytopenia because of cytoskeletal
alterations and accelerated platelet clearance (supplemental Figure 1).13 However, the precise role of Pfn1
for platelet function is unknown.
Here, we report that the lack of Pfn1 in platelets (Pfn1fl/fl-Pf4Cre) perturbs the organization of the adhesion-
dependent circumferential actin network and thereby results in accelerated integrin inactivation and hence
impaired platelet function in vitro and in vivo.
Methods
Animals, flow cytometry, aggregation, immunostaining, adhesion under flow, clot retraction, immunoblot-
ting, tail bleeding assay, in vivo model, Ca21 measurements, atomic force microscopy, and statistical
analyses are described in the supplemental Methods.13 Animal studies were approved by the district
government of Lower Franconia (Bezirksregierung Unterfranken).
Results and discussion
Impaired inside-out integrin activation in Pfn1fl/fl-Pf4Cre platelets
To study the role of Pfn1 in integrin function, platelet b1- and b3-integrin activation was assessed by flow
cytometry at different time points. Strikingly, Pfn1fl/fl-Pf4Cre platelets showed impaired activation of b1-
and b3-integrins (Figure 1A-B; supplemental Figures 2 and 3), whereas a-granule release (assessed by
P-selectin exposure; Figure 1C), as well as surface expression of b1- and b3-integrins, was only
marginally altered (supplemental Figure 4).
Submitted 7 November 2017; accepted 14 April 2018. DOI 10.1182/
bloodadvances.2017014001.
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© 2018 by The American Society of Hematology
1040 8 MAY 2018 x VOLUME 2, NUMBER 9
A
400 WT
Pfn1fl/fl-Pf4Cre300
200
**
JO
N/
A-
PE
 [M
FI
]
100
0
***
** *** ** ***
B
80
60
40
*
9E
G7
-F
ITC
 [M
FI
]
20
0
*
*** *** ** *
***
I
WT Pfn1fl/fl-Pf4Cre
Ta
il b
lee
din
g 
tim
e 
[m
in]
0
5
10
15
20
***
20
F
Su
rfa
ce
 c
ov
er
ag
e 
[%
]
0
10
20
30
40
50
60 ***
H
W
T
P
fn
1f
l/f
l-
  P
f4
C
re
[min]
0 30 60 90 120 180
*
C
200
160
120
80
CD
62
P-
FI
TC
 [M
FI
]
40
0
rest 10 1 10/1 0.1 0.01 10 1 1 1
RhdCVXCRPthrombinADP+
U46
U46
[U mL-1] [g mL-1]
ADP
[M]
E
WT
Pfn1fl/fl-Pf4Cre
ADP
[M]
Collagen
[g mL-1]
Thrombin
[U mL-1]
CRP
[g mL-1]
2.5
10.0 1.0
1.0
U46619
[M]
D
Fib
r-A
F4
88
 [M
FI
] ** **
***
[g mL-1][M]
rest
0
200
400
600
800
1000
1200
10/1 10 1 3
ADP+
U46
CRP Rhd Mn2+
[mM]
G
***
Re
lat
ive
 th
ro
m
bu
s
vo
lum
e 
[IF
I]
0
0.5
1.0
2.0
1.5
2.5
3.0
3.5
K
***
[C
a2
+ ]
i [
nM
]
0
basal
10
30
20
40
50
Re
sid
ua
l v
olu
m
e 
[L
]
0
50
100
150
200
250
300 ***
J **
WT Pfn1fl/fl-Pf4Cre
Tim
e 
to
 o
cc
lus
ion
 [m
in]
0
5
10
15
20
30
25
30
L
*
[C
a2
+ ]
i [
nM
]
0
0.01
Thr
[U mL-1]
1
CRP
[g mL-1]
1
TG
[M]
500
1500
1000 ***
***
0.01
Figure 1. Pfn1 deficiency impairs platelet integrin function. Activation of platelet aIIbb3- (JON/A-phycoerythrin [PE]) (A) and b1-integrins (9EG7-FITC) (B), as well as a-granule
release (anti-P-selectin-FITC) (C) in response to different agonists were assessed by flow cytometry after 15 minutes. FITC, fluorescein isothiocyanate. Antibodies were present throughout
the stimulation to assess maximal integrin activation at the respective time points. Values are mean 6 standard deviation (SD; n 5 6 vs 6). Impaired platelet aIIbb3- and a2b1-integrin
function was further revealed by flow cytometry assessing platelet fibrinogen binding (samples were stimulated for 10 minutes and Mn21 served as activation-independent positive control)
(D) and aggregation responses to different agonists (E). Values are mean 6 SD (n 5 6 vs 6). Aggregation traces are representative of at least 6 animals per group. Assessment of platelet
(F) adhesion and aggregate formation under flow (1000/s) on collagen I (70 mg/mL) (G) ofWT and platelet count-adjusted Pfn1fl/fl-Pf4Cre samples. Values are mean 6 SD (n 5 12 vs 12).
(H) Platelet clot retraction was determined over time in response to 5 U/mL thrombin and residual serum volume was quantified after 180 minutes at the end of the observation period.
Values are mean 6 SD (n 5 6 vs 6). In vivo, Pfn1 deficiency resulted in impaired hemostasis as assessed by a tail bleeding time assay (n 5 9 vs 9) (I) and a protection from arterial
thrombosis upon induction of a mechanical injury in the abdominal aorta (n 5 7 vs 6) (J). Basal [Ca21]i (n 5 17 vs 19) (K) and maximal increase of [Ca
21]i after stimulation with thrombin
(Thr), collagen-related peptide (CRP), or the sarco/endoplasmic reticulum Ca21 adenosine triphosphatase (SERCA) inhibitor thapsigargin (TG) of at least 9 vs 11 animals (L). Experiments
were performed in the presence of 1 mM extracellular Ca21. Each symbol in panels I and J represents 1 animal. Horizontal lines in panel I represent mean. ADP, adenosine diphosphate;
CVX, convulxin; Mn21, manganese; Rest, resting; Rhd, rhodocytin; U46, stable thromboxane A2 analog U46619. Unpaired Student t test (A-D, F-I, and K-L) and Fisher’s exact test (J) were
used to assess statistical differences between the groups: ***P , .001; **P , .01; *P , .05. NS, nonsignificant.
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The b3-integrin activation defect was further revealed by a decreased
binding of Alexa-F488-conjugated fibrinogen toPfn1fl/fl-Pf4Cre platelets at
all tested time points in response to agonist stimulation (Figure 1D;
supplemental Figure 5). Of note, irreversible fibrinogen binding was
almost indistinguishable between WT and Pfn1fl/fl-Pf4Cre platelets,
suggesting that receptor clustering is not altered by the Pfn1
deficiency (supplemental Figure 6). Surprisingly, aggregation
responses of Pfn1fl/fl-Pf4Cre platelets were only slightly affected by
the impaired integrin activation (Figure 1A,D-E; supplemental
Figures 2, 5, and 7), whereas the adhesion and aggregate formation
of Pfn1fl/fl-Pf4Cre platelets on collagen I under flow were markedly
reduced (Figure 1F-G; supplemental Figure 8). We speculate that the
reduced integrin function of Pfn1fl/fl-Pf4Cre platelets is still sufficient to
mediate platelet aggregation under static conditions, but insufficient to
resist shear forces generated under flow because of an impaired
connection of integrins and the actin cytoskeleton.
Pfn1 deficiency impairs integrin outside-in signaling
Pfn1fl/fl-Pf4Cre platelets displayed impaired integrin outside-in signaling,
as evidenced by almost abolished lamellipodia (WT, 58.0% 6 3.0% vs
Pfn1fl/fl-Pf4Cre, 18.5%64.3%; ***P, .001) and filopodia formation (WT,
46.9% 6 1.4% vs Pfn1fl/fl-Pf4Cre, 11.6% 6 1.5% ; ***P , .001) when
allowed to spread on fibrinogen (supplemental Figure 9).13,21 Similarly,
Pfn1fl/fl-Pf4Cre platelets showed severely delayed and less effective
clot retraction (Figure 1H), further reflecting impaired integrin function
and actin dynamics.10,13 Because Pfn1 is an effector of the RhoA/
Rho-associated kinase (ROCK) pathway, these findings are in agreement
with reports on RhoA-deficient platelets that show abolished clot
retraction.22 Furthermore, the strongly impaired filopodia and lamellipodia
formation of Pfn1fl/fl-Pf4Cre platelets suggests that Pfn1 acts as a key
effector in actin dynamics and integrin function downstream of Rho
guanosine triphosphatases (GTPases).23
Pfn1 is critical for hemostasis and thrombosis
In agreement with the in vitro data, Pfn1fl/fl-Pf4Cre mice displayed
prolonged bleeding times (13.3 6 2.7 minutes) as compared with
controls (7.2 6 2.3 minutes). Two out of 10 Pfn1fl/fl-Pf4Cre mice even
failed to cease bleeding within the observation period (Figure 1I).
Consistently, upon induction of arterial thrombosis by mechanical
injury of the abdominal aorta, all control mice formed occlusive thrombi
(4.061.2minutes), whereas 5 out of 6Pfn1fl/fl-Pf4Cremice did not form
stable occlusions (Figure 1J; supplemental Figure 10), thus revealing
Pfn1 as a critical factor for platelet function in hemostasis and
thrombosis. These defects appeared to be caused by the defective
integrin function of Pfn1fl/fl-Pf4Cre platelets, because degranulation was
normal (Figure 1C) and alterations in coagulation factors or other cell
types could be excluded because we capitalized on a megakaryocyte-
and platelet-specific conditional knockout mouse model.
Altered integrin and Tln1 localization in
Pfn1fl/fl-Pf4Cre platelets
Ca21 signaling is essential for platelet integrin activation; however,
contrary to a functional impairment we found an increased basal [Ca21]i
and enhanced store-operated Ca21 entry in Pfn1fl/fl-Pf4Cre platelets
(Figure 1K-L). This was most likely due to impaired actin dynamics in the
absence of Pfn1,13 because inhibition of activation-dependent actin-
polymerization was shown to increase store-operated Ca21 entry.24
Besides Ca21 signaling, Tln1 recruitment to b-integrin tails
represents a key step in integrin activation. Whereas in spread
control platelets Tln1 and b3-integrins colocalized at the cell cortex,
we found a diffuse colocalization pattern in Pfn1fl/fl-Pf4Cre platelets,
suggesting impaired b3-integrin localization or Tln1 recruitment
as cause for the observed defects (Figure 2A-B). Strikingly, the
localization of Tln1 and b3-integrins at the cell cortex of control
platelets coincided with a high cellular stiffness, reminiscent of
the cortical cytoskeleton.20 Pfn1fl/fl-Pf4Cre platelets, however, only
displayed focal spots of increased stiffness on the cell cortex,
strongly resembling the random colocalization pattern of Tln1,
b3-integrins, and the disrupted cortical actin cytoskeleton
(Figure 2A-D; supplemental Figure 11). These results indicate that
the impaired cytoskeletal dynamics in Pfn1fl/fl-Pf4Cre platelets may
account for the altered recruitment to, or stabilization of, integrins
and/or Tln1 at the leading edge of spread platelets.9-13
Accelerated integrin inactivation in
Pfn1fl/fl-Pf4Cre platelets
We recently showed that the organization of the circumferential actin-
cytoskeleton modulates calpain-mediated inactivation of activated
platelet b3-integrins and thereby also controls their localization.10
Based on this, together with the disrupted cortical actin-cytoskeleton
and the enhanced Ca21 signaling in Pfn1fl/fl-Pf4Cre platelets, we
Figure 2. Accelerated integrin inactivation in Pfn1fl/fl-Pf4Cre platelets. (A) b3-integrin (Itgb3) localization and recruitment of talin-1 (Tln1) to b-integrin tails was assessed
by immunostaining and confocal microscopy (Leica TCS SP5, 1003/1.4 oil STED White objective, Leica Microsystems) of fibrinogen-spread platelets (n 5 6 vs 6). Scale bars,
3 mm. (B) Assessment of the Tln1 and b3-integrin distribution pattern in at least 70 platelets of 6 animals per group. Values are mean 6 SD (n 5 6 vs 6). Representative
heat maps (C) and histograms (D) of the cellular stiffness measured by atomic force microscopy on fibrinogen-spread platelets of 5 animals per group. Washed platelets
were stimulated for 5 or 30 minutes with thrombin (Thr, T) and collagen-related peptide (CRP, C) (E-F) or CRP alone (G). Activation of aIIbb3-integrins and phosphatidylserine
exposure on the outer leaflet of the platelet membrane were determined by adding JON/A-PE antibody and Anxa5-FITC protein 5 minutes prior to the end of the incubation
time. Analysis was performed by flow cytometry. Flow cytometry plots are representative of at least 6 animals per group. (F-G) Percentage of platelets per quadrant (Q); Q1,
JON/A1 Anxa52 (upper left); Q2, JON/A1 Anxa51 (upper right); Q3, JON/A2 Anxa51 (lower right); Q4, JON/A2 Anxa52 (lower left). Values are mean 6 SD of 6 vs 7 animals.
Resting (H-I) or 2.5 mM latrunculin A-pretreated (J-K) platelets were left untreated or preincubated for 10 minutes in the presence of the calpain inhibitor MDL-28170
(200 mM). Subsequently, samples were stimulated with the calcium ionophore A23187 (10 mM) or thrombin (0.1 U/mL) and CRP (10 mg/mL), lysed, and processed for
immunoblotting. Full-length (Ab762) and calpain-cleaved (AbD747) b3-integrin were probed with the respective antibodies and analyzed by densitometry. Glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) served as control. Values are mean 6 SD of 6 vs 7 animals. (H,J) Immunoblots are representative of at least 6 animals per group. Platelets
were either pretreated with 5 mM of the actin polymerization inhibiting drug cytochalasin D (L) or 200 mM of the calpain inhibitor MDL-28170 (M-N). Subsequently, the
activation and localization of b3-integrin and Tln1 was assessed by flow cytometry (L,N) or immunostaining and confocal microscopy (Leica TCS SP5, 1003/1.4 oil STED
White objective, Leica Microsystems) on fibrinogen-spread platelets (M). Values are mean 6 SD of 4 vs 4 animals. Unpaired Student t test was used to assess
statistical differences between the groups: ***P , .001; **P , .01; *P , .05.
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hypothesized that Tln1 and b3-integrins might be more prone to
calpain-mediated cleavage and that this could account for the altered
localization and impaired function of integrins in Pfn1fl/fl-Pf4Cre platelets.
In support of this, we found a significantly increased percentage of
phosphatidylserine-positive Pfn1fl/fl-Pf4Cre platelets with inactivated
integrins (JON/A2 Anxa51; lower right quadrant) after both 5 minutes
(WT, 18.2% 6 5.6% vs Pfn1fl/fl-Pf4Cre, 32.6% 6 4.1%; ***P , .001)
and 30minutes (WT, 50.9%6 8.7% vs Pfn1fl/fl-Pf4Cre, 65.6%6 4.3%;
**P , .01) upon stimulation with thrombin and CRP (Figure 2E-F;
supplemental Figure 12A,C). Similar observations were made upon
stimulation with CRP alone, but not when using the A23187 ionophore
that efficiently induces phosphatidylserine exposure without integrin
activation (Figure 2G; supplemental Figure 12A-B,D-F). Remarkably,
stimulated Pfn1fl/fl-Pf4Cre platelets displayed an increased loss of
b3-integrin, Tln1, and filamin A as compared with control that could
be fully rescued by chemical inhibition of calpain or actin assem-
bly, suggesting that enhanced calpain-mediated integrin inactiva-
tion due to an insufficient cytoskeletal linkage may account for the
observed defects in Pfn1fl/fl-Pf4Cre platelets (Figure 2H-K; supplemental
Figures 13 and 14). In support of this, pretreatment of platelets with
the actin polymerization inhibitor cytochalasin D overall reduced b3-
integrin activation but, most importantly, diminished the differences
between WT and Pfn1fl/fl-Pf4Cre platelets (Figures 1A and 2L;
supplemental Figure 2). Moreover, chemical inhibition of calpain
improved the spreading of Pfn1fl/fl-Pf4Cre platelets and restored the
localization as well as activation of b3-integrins and Tln (Figure 2M-N).
In summary, these results revealed that the defective organization of
the cortical cytoskeleton in Pfn1fl/fl-Pf4Cre platelets leads to accelerated
integrin inactivation and hence impaired platelet function. Based on the
patchy colocalization pattern of Tln1, b3-integrins, and the disrupted
cytoskeleton in Pfn1fl/fl-Pf4Cre platelets, it is tempting to speculate
that Pfn1 might act as an organizer of the adhesion-dependent,
circumferential actin network, thereby linking integrins to the underlying
cytoskeleton and limiting calpain-mediated integrin inactivation.24 In
support of this, we have found increased Pfn1 activity in Twf2a2/2
platelets, which resulted in a thickened cortical cytoskeleton and
sustained integrin activation due to limited calpain-mediated inactiva-
tion.10 However, an increased calpain activity due to the impaired actin
dynamics in Pfn1fl/fl-Pf4Cre platelets also needs to be considered.
In summary, our findings highlight a central role of Pfn1-mediated actin
rearrangements for normal platelet integrin function and turnover with
implications for hemostasis and thrombosis.
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